Systemic Distribution and Biological Safety of Mesoporous Bioactive Glass Nanoparticles by 45ca Labeling, Tracing, and Histological Evaluation
Sui Baiyan,Zhong Gaoren,Sun Jiao
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.01641
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event Systemic distribution and biological safety of mesoporous bioactive glass nanoparticles by 45Ca labeling, tracing, and histological evaluation Baiyan Sui1, Gaoren Zhong1* and Jiao Sun1 1 Shanghai Jiaotong University School of Medicine, Shanghai Biomaterials Research & Testing Center, Ninth People’s Hospital, China Introduction: Mesoporous bioactive glass (MBG) nanoparticles had the advantage of high loading efficiency[1], but it is still unknown its state in vivo on early stage, which is directly bearing on pharmacodynamics and the organism’s biological risks. Therefore, it is necessary to explicit the distribution and potential risks to organism. In this study, the synthesis of MBG nanoparticle was introduced by radionuclide calcium (45Ca), the distribution of MBG nanoparticle in major tissues and organs was analyzed within 72 hours. Finally, whether MBG nanoparticle caused a histopathologic reaction was evaluated. Experimental Section: A hydrothermal method using 45Ca (NO3)2·4H2O, TEOS and TEP in combination with CTAB and PVP co-templates was applied to prepare 45Ca-MBG nanoparticles. MBG nanoparticles were characterized by transmission electron microscopy (TEM). The size and zeta potential in physiological saline were performed on a ZetaSizer. Then twenty ICR mice were intravenously injection by 45Ca-MBG nanoparticles. Then the blood, heart, lung, liver, spleen, and kidney were harvested, and the tissue distribution was expressed as the percentage injected dose per gram tissue (%ID/g). Finally ICR mice were injected via tail vein with nanoparticles (physiological saline set as control). After 72h, the major organs were collected, and the histopathological change was evaluated. Results and Discussion: The establishment of an effective labeling technique is considered to come first on monitoring the distribution of MBG nanoparticles in vivo. In this study, the size of obtained 45Ca-MBG nanoparticles with a mesostructure was in the range of 50-100 nm (Figure 1). The hydrodynamic size, increased by slightly agglomeration, was 177.7nm. The nanoparticles remained the low negative surface charge (-11.7mV) which may be suitable as a drug vehicle in clinical. Furthermore, the nanoparticles were mainly distributed in the blood and major organs (Figure 2). The radioactivity peaked at 12 hours and then declined gradually. The accumulation of MBG nanoparticles in liver was higher than that of other organs. This phenomenon could be interpreted that the size of MBG nanoparticles, which was smaller than the reticuloendothelial gap of liver, was in favor of intrahepatic transport[2]. Ultimately, there was no obvious pathological change in the major organs. Conclusion: This study has created an effective quantitative tracer for the 45Ca labeling of MBG nanoparticles. The results demonstrated that post injection in mice, 45Ca-MBG nanoparticles distributed in the heart, lungs, liver, spleen and kidneys through blood circulation, and did not cause histopathological changes. These findings preliminarily addressed the benefits and risks of MBG nanoparticles as nano drug delivery. Figure 1. TEM image for MBG nanoparticles Figure 2. Quantitative tissue distribution of 45Ca-MBG nanoparticle in major tissues References:[1] Wu C, Fan W, Chang J. Functional mesoporous bioactive glass nanospheres: synthesis, high loading efficiency, controllable delivery of doxorubicin and inhibitory effect on bone cancer cells[J]. Journal of Materials Chemistry B, 2013, 1(21): 2710-2718.[2] Xie G, Sun J, Zhong G, et al. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice[J]. Archives of toxicology, 2010, 84(3): 183-190. Keywords: in vivo, nanoparticle, Biocompatibility, vehicle Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: Poster Topic: Biomaterials evaluation in animal models Citation: Sui B, Zhong G and Sun J (2016). Systemic distribution and biological safety of mesoporous bioactive glass nanoparticles by 45Ca labeling, tracing, and histological evaluation. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01641 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. * Correspondence: Dr. Gaoren Zhong, Shanghai Jiaotong University School of Medicine, Shanghai Biomaterials Research & Testing Center, Ninth People’s Hospital, Shanghai, China, Email1 Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Baiyan Sui Gaoren Zhong Jiao Sun Google Baiyan Sui Gaoren Zhong Jiao Sun Google Scholar Baiyan Sui Gaoren Zhong Jiao Sun PubMed Baiyan Sui Gaoren Zhong Jiao Sun Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.